- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
76
High return on equity, past performance and sound balance sheet.
76 companies
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م3.6b
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
AXPH
ج.م727.53
7D
12.1%
1Y
217.7%
Lotus Pharmaceutical
Market Cap: NT$50.8b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$195.00
7D
0.8%
1Y
-26.8%
JW Shinyak
Market Cap: ₩79.6b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,501.00
7D
-0.9%
1Y
2.3%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥18.2b
Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.
300573
CN¥71.20
7D
3.6%
1Y
22.3%